ERYTECH Pharma announces the oral presentation of very demonstrative results regarding its technology to Induce specific immune tolerance by antigen loaded erythrocytes. Post author:admERY Post published:September 7, 2012 Post category:Newsroom You Might Also Like ERYTECH proposes the appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors May 6, 2019 ERYTECH to Webcast Presentation at Jefferies 2017 London Healthcare Conference November 14, 2017 ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018 June 15, 2018
ERYTECH proposes the appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors May 6, 2019
ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018 June 15, 2018
